1159977-04-4|Ziprasidone impurity E - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Ziprasidone impurity E | CAS:1159977-04-4

Ziprasidone impurity E

Name：Ziprasidone impurity E
CAS：1159977-04-4
Synonyms：3-(1,2-Benzisothiazol-3-yl)-5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one
Molecular Formula：C₂₈H₂₄ClN₅OS₂
Molecular Weight：546.11
EINESC：

Description

Properties

Density	1.427±0.06 g/cm3 (20 º

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Self-assembled 1, 2-bis [4-(4-(10-decyloxy) phenylazo)] benzoylhydrazine dimer and its hydrogen-bonded complexes.Yeap G-Y, et al. Supramolecular Chemistry, 25(7), 424-431 (2013) Journal of Agricultural and Food Chemistry, 43, 219-219 (1995) Helvetica Chimica Acta, 68, 1444-1444 (1985) Octanol/Water partition coefficient of substituted benzene derivatives containing halogens and carboxyls: Determination using the shake-flask method and estimation using the fragment method. Qiao Y, et al. Journal of Chemical and Engineering Data, 53(1), 280-282 (2007) Selective lithiation/carbonation of polyhalobenzenes: an improved synthesis of furosemide-7-14C. Perry CW, et al. The Journal of Organic Chemistry, 43(22), 4391-4391 (1978) A New and Versatile Synthesis of Thioflavanones from 2-Fluorobenzoic Acids. Lee JI. J. Korean Chem. Soc., 58(4) (2014)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News